Welcome to this edition of the Sanofi quarterly newsletter! These newsletters, created by Sanofi, aim to provide education to healthcare providers on relevant topics in multiple myeloma (MM). This edition will focus on hypogammaglobulinemia (HGG) and will include an overview of the clinical impact of HGG-associated infections, current strategies for infection management, and future directions for the management of HGG in MM.

In this issue:

• Infections in MM
• Immunoglobulin dysfunction in MM
• Definition and impact of HGG in MM
• HGG management strategies
• Infections in the era of novel MM therapies
• Unmet need and future directions